Syntekabio, Inc. is a bioinformatics company. It manages and analyzes genome analysis and massive bio data and genome. The company was founded by Jongsun Jung in 2009 and is headquartered in Daejeon, South Korea.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 226330 is 6,540 KRW — it has decreased by −1.58% in the past 24 hours. Watch SYNTEKABIO,INC. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange SYNTEKABIO,INC. stocks are traded under the ticker 226330.
226330 stock has risen by 17.90% compared to the previous week, the month change is a 14.74% rise, over the last year SYNTEKABIO,INC. has showed a −41.87% decrease.
226330 reached its all-time high on Oct 5, 2020 with the price of 48,700 KRW, and its all-time low was 4,200 KRW and was reached on Oct 29, 2024. View more price dynamics on 226330 chart. See other stocks reaching their highest and lowest prices.
226330 stock is 9.41% volatile and has beta coefficient of 1.03. Track SYNTEKABIO,INC. stock price on the chart and check out the list of the most volatile stocks — is SYNTEKABIO,INC. there?
Today SYNTEKABIO,INC. has the market capitalization of 104.52 B, it has increased by 19.34% over the last week.
226330 net income for the last quarter is −2.66 B KRW, while the quarter before that showed 677.08 M KRW of net income which accounts for −492.42% change. Track more SYNTEKABIO,INC. financial stats to get the full picture.
No, 226330 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 21, 2024, the company has 54.00 employees. See our rating of the largest employees — is SYNTEKABIO,INC. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SYNTEKABIO,INC. EBITDA is −11.50 B KRW, and current EBITDA margin is −8.73 K%. See more stats in SYNTEKABIO,INC. financial statements.
Like other stocks, 226330 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SYNTEKABIO,INC. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SYNTEKABIO,INC. technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SYNTEKABIO,INC. stock shows the sell signal. See more of SYNTEKABIO,INC. technicals for a more comprehensive analysis. If you're still not sure, try looking for inspiration in our curated watchlists.